Program Description: |
Johns Hopkins is a core center of the BMT clinical trials network; COG approved. Current studies are looking at ways to facilitate graft tolerance to reduce the risk of GVHD and reduce graft rejection in patients with mismatched donors, as well as investigating safer ways to transplant non-malignant diseases. Some patients with fully matched donors do not require immune suppression beyond four days after transplantation. |
Contact Information: |
If you have transplant-related questions, please contact Rebekah Zonozy, transplant center coordinator, at (410) 955-4724 or by e-mail at rwrigh28@jhmi.edu. |
Program Type: |
Adult and Pediatric |
Attending Physicians:
(Medical Doctors) |
Adult - Richard Ambinder, Javier Bolanos-Meade, Ivan Borrello, Robert Brodsky, Hetty Carraway, Amy Dezern, Ephraim Fuchs, Jonathan Gerber, Nilanjan Ghosh, Douglas Gladstone, Ivana Gojo, Steven Gore, Carol Ann Huff, Richard Jones, Yvette Kasamon, Mark Levis, Leo Luznik, William Matsui, Jonathan Powell, Keith Pratz, B. Douglas Smith, Lode Swinnen
Pediatric - Robert Arceci, Patrick Brown, Allen R. Chen, Kenneth Cohen, Jason Farrar, Alan Friedman, Christopher Gamper, David Loeb, Ido Paz-Priel, Rachel Rau, Eric Schafer, Donald Small, Heather Symons, Elias Zambidis |
Transplants Performed: |
Marrow/PBSC, single cord, and double cord |
Cord blood transplants performed on: |
Adult and pediatric |
Explain Transplant Center HLA Match Requirements
Estimated Search & Transplant Costs
The costs for a transplant vary greatly from center to center and depend
on factors such as health insurance, disease type and disease stage of
the patient, as well as center-specific billing policies. Examples of
costs in the search and transplant include:
- The amount and geographic location of donors tested
- Testing needed to confirm a match
- Processing and collecting of tissue-typing samples
- Donor workup testing needed
- Getting the marrow, PBSC or cord blood unit for transplant
For the best understanding of costs of transplant and follow-up for a
specific transplant center, contact the center's Financial Representative.
Explain Transplant Costs at Different Centers
Financial Services:
Financial services at this center could include:
- Health insurance information
- Financial assistance
- Patient-related resources
|
Resources for financial information
If you have questions about costs and financial services at this
transplant center, you can contact the center's financial
representative, Patrice McMullen by e-mail at mcmulpa@jhmi.edu or by phone at (410) 955-2549.
Many organizations exist to help patients with lodging, transportation and
other transplant-related expenses. Visit the National Marrow Donor Program's
Patient Organizations database
for more information. Financial assistance resources are also listed
on this Web site.
|
Transplant Experience
This center has been performing allogeneic transplants since 1969 and has been an NMDP transplant center since October 1997.
Transplants Reported
(From Jan. 2010 to Dec. 2011
as reported by the centers)
|
Unrelated or Related Donor |
Auto-
logous
(PBSC or marrow) |
Total(by transplant type) |
Total Non-
Myeloablative transplants* |
Marrow |
PBSC |
Cord
Blood |
| Unrelated Donor - Adult |
50 |
5 |
0 |
--- |
55 |
17 |
| Unrelated Donor - Pediatric |
3 |
2 |
2 |
--- |
7 |
3 |
| Related Donor - Adult |
226 |
9 |
0 |
--- |
235 |
162 |
| Related Donor - Pediatric |
22 |
1 |
0 |
--- |
23 |
9 |
| Autologous - Adult |
--- |
--- |
--- |
99 |
99 |
--- |
| Autologous - Pediatric |
--- |
--- |
--- |
12 |
12 |
--- |
| Total (by cell source) |
301 |
17 |
2 |
111 |
431 |
191 |
*The total Non-Myeloablative transplants column shows a subset of the total number of transplants by type.
To locate centers that perform cord blood transplants, use the search tool on this site.
The NMDP also has Transplants by Disease Charts available showing the number of NMDP coordinated transplants by disease category at each U.S. transplant center.
Explain Transplant Experience
Center-Specific Analysis
This analysis includes ONLY patients who received their FIRST ALLOGENEIC* transplant
between January 1, 2008 and December 31, 2010 using unrelated or related donors, and
who had at least a 100-day follow-up.
- This center reported survival status data for 395 patients.
- The actual one-year survival of these patients is 73%.
- Based on a national average for patients like those transplanted at this center, 95% of the time the one-year survival is expected to be between 63% and 72% for patients at this center.
- This center's actual results are above the expected range for this center.
*Allogeneic means using cells from a person other than the patient.
For help with understanding these statistics, please see Understanding Transplant Outcomes (PDF).
Survival by Patient's Age, Disease Type and Stage
If you do not find your disease in the statistics below, it may be combined with other similar diseases in a category. Please refer to our broad disease categories page for more information.
Further information about this center, including the number and type of
transplants performed in each of the last three years, and the support groups
offered, may be found in the BMT InfoNet Transplant Center Directory:
http://www.bmtinfonet.org/transplantcenters.
BMT InfoNet (Blood & Marrow Transplant Information Network) is a
nonprofit organization that provides information and emotional support
to transplant patients and their families.
Please take a
brief
survey to share your feedback on the transplant center informational listings.